"Interleukin-10" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.
Descriptor ID |
D016753
|
MeSH Number(s) |
D12.644.276.374.465.510 D12.776.467.374.465.510 D23.529.374.465.510
|
Concept/Terms |
Interleukin-10- Interleukin-10
- Interleukin 10
- IL10
- IL-10
- CSIF-10
- Cytokine Synthesis Inhibitory Factor
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-10".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-10".
This graph shows the total number of publications written about "Interleukin-10" by people in this website by year, and whether "Interleukin-10" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 7 | 1 | 8 |
1998 | 0 | 2 | 2 |
1999 | 1 | 1 | 2 |
2000 | 1 | 3 | 4 |
2001 | 1 | 0 | 1 |
2002 | 2 | 2 | 4 |
2003 | 0 | 6 | 6 |
2004 | 2 | 4 | 6 |
2005 | 1 | 1 | 2 |
2006 | 4 | 2 | 6 |
2007 | 3 | 1 | 4 |
2008 | 0 | 2 | 2 |
2009 | 1 | 1 | 2 |
2010 | 2 | 5 | 7 |
2011 | 2 | 3 | 5 |
2012 | 3 | 1 | 4 |
2013 | 4 | 0 | 4 |
2014 | 4 | 6 | 10 |
2015 | 2 | 2 | 4 |
2016 | 2 | 5 | 7 |
2017 | 0 | 5 | 5 |
2018 | 0 | 4 | 4 |
2019 | 2 | 1 | 3 |
2020 | 2 | 3 | 5 |
2021 | 1 | 2 | 3 |
2022 | 2 | 0 | 2 |
2023 | 2 | 1 | 3 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-10" by people in Profiles.
-
Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell. 2025 Jan 13; 43(1):69-85.e11.
-
Immunologic Profiling of CSF in Subarachnoid Neurocysticercosis Reveals Specific Interleukin-10-Producing Cell Populations During Treatment. Neurol Neuroimmunol Neuroinflamm. 2024 Nov; 11(6):e200320.
-
Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain. Brain Behav Immun. 2025 Jan; 123:399-410.
-
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
-
LPS-induced whole-blood cytokine production and depressive symptoms in dementia spousal caregivers: The moderating effect of childhood trauma. Psychoneuroendocrinology. 2024 Oct; 168:107140.
-
Interleukin-10 in cancer immunotherapy: from bench to bedside. Trends Cancer. 2023 09; 9(9):716-725.
-
Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome. EBioMedicine. 2023 Jun; 92:104603.
-
Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice. Microb Cell Fact. 2023 May 09; 22(1):96.
-
Resolution of cisplatin-induced fatigue does not require endogenous interleukin-10 in male mice. Behav Brain Res. 2023 04 27; 444:114381.
-
Acute high-fat diet impairs macrophage-supported intestinal damage resolution. JCI Insight. 2023 02 08; 8(3).